Specific block of androgen receptor activity by antisense oligonucleotides

被引:0
作者
F Hamy
V Brondani
R Spoerri
S Rigo
C Stamm
T Klimkait
机构
[1] Novartis AG,Oncology Department
[2] Pharma Research,undefined
[3] Institute for Medical Microbiology,undefined
[4] University of Basel,undefined
来源
Prostate Cancer and Prostatic Diseases | 2003年 / 6卷
关键词
antisense; androgen receptor; prostate-specific antigen; probasin; gene regulation; LNCaP; prostate cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Claims about molecular mechanisms underlying the resistance to anti-hormones of prostate cancer cells find support in biological experiments, which involve hormone-independent activation of the androgen receptor's (AR) transcriptional activity. In order to test this hypothesis, we attempted to shut down the expression of AR by the means of target-directed antisense oligonucleotides. A set of 49 oligonucleotides matching sequences of the AR mRNA either in the coding sequence or in the 3′ and 5′ untranslated regions were synthesized and examined in a cellular AR-dependent reporter system. Five antisense oligonucleotides were identified as highly potent inhibitors of AR-driven gene expression in a cellular reporter assay. These five were further profiled using point-mutated control sequences for the assessment of AR inhibition. In addition the expression of another AR-driven gene, the modulator of PSA expression (gene for inhibition of prostate specific antigen, an endogenous, AR-driven gene) was examined. Finally, we observed that the hormone-independent but AR-mediated transactivation by IGF-1 could also be specifically shut-down by these antisense oligonucleotides. The selection of highly target-restricted antisense oligonucleotides in the prostate cancer cell line LNCaP provided tools to study a central role of the androgen receptor in growth regulation of prostatic cancer cell lines and could be of utility in cancer situations in vivo.
引用
收藏
页码:27 / 33
页数:6
相关论文
共 50 条
  • [21] Differential transactivation by the androgen receptor in prostate cancer cells
    Snoek, R
    Bruchovsky, N
    Kasper, S
    Matusik, RJ
    Gleave, M
    Sato, N
    Mawji, NR
    Rennie, PS
    PROSTATE, 1998, 36 (04) : 256 - 263
  • [22] Antisense oligonucleotides: The state of the art
    Aboul-Fadl, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (19) : 2193 - 2214
  • [23] The concept and application of antisense oligonucleotides
    Yacyshyn, BR
    Crooke, ST
    DISEASES OF THE COLON & RECTUM, 2001, 44 (09) : 1241 - 1243
  • [24] Molecular Mechanisms of Antisense Oligonucleotides
    Crooke, Stanley T.
    NUCLEIC ACID THERAPEUTICS, 2017, 27 (02) : 70 - 77
  • [25] Engineered repressors are potent inhibitors of androgen receptor activity
    Brooke, Greg N.
    Powell, Sue M.
    Lavery, Derek N.
    Waxman, Jonathan
    Buluwela, Laki
    Ali, Simak
    Bevan, Charlotte L.
    ONCOTARGET, 2014, 5 (04) : 959 - 969
  • [26] Delivery systems for antisense oligonucleotides
    Garcia-Chaumont, C
    Seksek, O
    Grzybowska, J
    Borowski, E
    Bolard, J
    PHARMACOLOGY & THERAPEUTICS, 2000, 87 (2-3) : 255 - 277
  • [27] Modulating the Activity of Androgen Receptor for Treating Breast Cancer
    You, Chan-Ping
    Tsoi, Ho
    Man, Ellen P. S.
    Leung, Man-Hong
    Khoo, Ui-Soon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [28] HUMAN ANDROGEN RECEPTOR-BINDING TO THE ANDROGEN RESPONSE ELEMENT OF PROSTATE-SPECIFIC ANTIGEN
    LUKE, MC
    COFFEY, DS
    JOURNAL OF ANDROLOGY, 1994, 15 (01): : 41 - 51
  • [29] Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
    Zhang, Keke
    Yan, Fei
    Lei, Xiaoying
    Wei, Di
    Lu, Huanyu
    Zhu, Zheng
    Xiang, An
    Ye, Zichen
    Wang, Li
    Zheng, Wanxiang
    Li, Xi'an
    Yuan, Jiarui
    Lu, Zifan
    Yuan, Jianlin
    MOLECULAR MEDICINE REPORTS, 2018, 17 (06) : 8203 - 8211
  • [30] Repression of Cell Proliferation and Androgen Receptor Activity in Prostate Cancer Cells by 2′-Hydroxyflavanone
    Ofude, Mitsuo
    Mizokami, Atsushi
    Kumaki, Misako
    Izumi, Kouji
    Konaka, Hiroyuki
    Kadono, Yoshifumi
    Kitagawa, Yasuhide
    Shin, Minkyoung
    Zhang, Jian
    Keller, Evan T.
    Namiki, Mikio
    ANTICANCER RESEARCH, 2013, 33 (10) : 4453 - 4461